Thearubigins (TR) are polymeric flavanol-derived compounds formed during the fermentation of tea leaves. Comprising B70% of total polyphenols in black tea, TR may contribute majorly to its beneficial effects on health. To date, there is no appropriate food composition data on TR, although several studies have used data from the US Department of Agriculture (USDA) database to estimate TR intakes. We aimed to estimate dietary TR in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort and assess the impact of including TR or not in the calculation of the total dietary flavonoid intake. Dietary data were collected using a single standardized 24-h dietary recall interviewer-administered to 36 037 subjects aged 35-74 years. TR intakes were calculated using the USDA database. TR intakes ranged from 0.9 mg/day in men from Navarra and San Sebastian in Spain to 532.5 mg/day in men from UK general population. TR contributed o5% to the total flavonoid intake in Greece, Spain and Italy, whereas in the UK general population, TR comprised 48% of the total flavonoids. High heterogeneity in TR intake across the EPIC countries was observed. This study shows that total flavonoid intake may be greatly influenced by TR, particularly in high black tea-consuming countries. Further research on identification and quantification of TR is needed to get more accurate dietary TR estimations.
INTRODUCTION
Nowadays, much attention is paid to black tea due to its potential role in chronic disease prevention, such as cardiovascular disease 1 and some types of cancer, such as colorectal cancer; 2 although, this evidence is still inconsistent. 3 Thearubigins (TR)
form the most abundant subclass of polyphenols found in black tea, comprising B70% of the total; 4,5 therefore, TR could have an important role in these beneficial effects of black tea on health, particularly in high black tea-consuming countries. TR are oligo/polymeric flavonoids classified further as flavanolderived compounds. 6 They are only formed during the fermentation of tea (Camellia sinensis) leaves, which induces both enzymatic and non-enzymatic oxidations of flavan-3-ol monomers leading to the formation of two major groups of pigments: TR and theaflavins. 4 Although they were first observed in 1959, the term 'thearubigins' was not introduced until 1962. Fifty years later, these complex and structurally heterogeneous compounds still remain poorly characterized. 5, 7, 8 TR in foods are quantified using an indirect method by subtracting the total of the structurally identified phenolic compounds (obtained through HPLC analysis) from the total phenolic content (obtained using the Folin-Ciocalteu assay), 9 thus the TR content is merely an approximation.
Despite the spectrophotometric method not being specific for TR, several studies have included the TR composition data obtained from it in their estimations of flavonoid intakes. [10] [11] [12] Therefore, the aim of the current study was first to estimate the TR intake, using the data from the indirect method mentioned above, and, secondly, to assess the potential contribution the TR would have made to the total flavonoid intake compared with the previous estimates in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. 13 
MATERIALS AND METHODS
EPIC is an ongoing large cohort study of diet, lifestyle and health, having recruited over half a million people in 10 European countries. In the calibration study, a random sample stratified by age, sex and center, and weighted for the expected cancer cases in each stratum (36 994 subjects, B8% of the entire EPIC cohort) completed a standardized 24-h dietary recall (24-HDR) between 1995 and 2000.
14 EPIC cohorts were mostly population-based (Bilthoven, The Netherlands; Greece; Germany; Sweden; Denmark; Norway; Cambridge and a small part of the Oxford cohort from the UK), with some exceptions: women members of a health insurance for school employees (France); women attending breast cancer screening (Utrecht, the Netherlands); blood donors (some centers in Italy and Spain) and a cohort consisting predominantly of vegetarians ('health-conscious group' in Oxford, UK).
14 After the exclusion of 945 subjects aged o35 or 474 years, due to low number of subjects in these age categories, and 16 subjects without baseline dietary data, a total of 36 037 subjects were included. An approval for the EPIC study was obtained from all ethical review boards of the participating institutions. All participants provided written informed consent.
Dietary information at baseline was obtained through a single standardized 24-HDR interview using a computerized software (EPICSoft). 15, 16 The interview procedure was standardized to describe and quantify all of the foods and beverages consumed the previous day with no omissions. The food composition data on TR were compiled from the 2007 USDA database. 4 TR have been quantified/estimated in the leaves of black tea (5.9 g/100 g), oolong tea (3.0 g/100 g) and green tea (0.1 g/100 g), and therefore in their infusions (black tea: 81 mg/100 ml; oolong tea: unknown content; green tea: 1.1 mg/100 ml). 4 However, the methodology for the quantification of TR is inaccurate and obsolete. 9 Total dietary flavonoid data without TR in EPIC was estimated elsewhere. 13 Dietary flavonoid intakes were estimated using generalized linear models and presented as means with standard errors (s.e.) stratified by sex and center, and adjusted for age and weighted by season and day of the week of the 24-HDR to control for different distributions of participants across seasons and 24-HDR days. The contribution of TR to the total intake was calculated as a percentage. The contribution of tea to overall flavonoid intake by four European regions (defined as (i) Mediterranean countries: all centers in Greece, Spain, Italy and the south of France; (ii) nonMediterranean countries: all centers in the north-east and north-west of France, Germany, the Netherlands, Denmark, Sweden and Norway; (iii) UK general population; (iv) UK health-conscious group (mostly based on vegetarians)) was also computed as a percentage. All analyses were conducted using the SPSS Statistics software (version 19.0, SPSS Inc., Chicago, IL, USA).
RESULTS AND DISCUSSION
There were great differences in TR intakes across EPIC centers (Table 1) . For men, mean TR intake ranged from 0.9 mg/day (Navarra and San Sebastian, Spain) to 532.5 mg/day (UK general population), whereas for women the range was from 1.2 mg/day (Navarra, Spain) to 455.6 mg/day (UK general population). Figure 1 shows the adjusted mean intake of dietary total flavonoids with and without TR. Tea is the only food contributor of TR intake, and thus the differences in the total flavonoid intake were due to the differences in tea consumption patterns. In Mediterranean countries (Greece, Spain and Italy), the inclusion of TR in the estimation of total flavonoids may not have much impact (o5%), because tea is not extensively consumed. 11 Contribution of TR to Thearubigin intake in EPIC-Europethe total flavonoid intake was between 15-30% in Sweden, Germany, Norway, France and Denmark, and between 35-40% in the Netherlands and the UK health-conscious group. Whereas, in the UK general population, where tea consumption is the highest, TR contributed 48% to the total flavonoid intake. Comparable results were observed in Australia, where the reported TR intake in adults was 213 mg/day, accounting for 47% of the total flavonoids. 12 Similar results on TR intake have also been suggested in studies from the USA, Denmark and the Netherlands, although it is difficult to find these data specifically in these papers because they are presented by flavonoid subgroups (flavan-3-ols) and not by individual compounds. 10, 12 In the UK general population, tea flavonoids (mainly flavan-3-ol monomers, proanthocyanidins, theaflavins, TR and flavonols) comprised 73.5% of the total flavonoid intake when TR were accounted for, while they comprised only 48.5% when TR were excluded from the calculation of the total flavonoids. In the UK health-conscious group, tea flavonoids contributed 59.4% (33.2% when TR were excluded). In non-Mediterranean countries, tea flavonoids contributed 42.0% (23.2% when TR were excluded), whereas in the Mediterranean countries, they only accounted for 13.1% (6.8% when TR were excluded).
Despite the potential impact that TR could have on the total flavonoid estimations, there is not yet a specific and accurate analytical method to quantify TR. The non-specific spectrophotometric method used to date 9 only provides a crude estimation of the TR concentrations in teas. Fourier transform infrared spectroscopy 17 and pyrolysis-gas chromatography-mass spectrometry 18 are potential methods to analyze high-molecular weight polyphenols, although they need to be further explored to estimate TR in tea.
As mentioned above, the principal limitation of this study is the lack of reliable food composition data on TR. For this reason, our results are only an attempt to evaluate the potential impact of including current food composition data on TR in European diets. Another limitation is the use of a single 24-HDR, which is less likely to reflect the true usual individual diet. However, our analyses of the 24-HDR were weighted by season of the year and weekday of dietary recall, and can, therefore, be considered as a useful method to describe the average dietary intake of a population, particularly when estimated based on a large number of subjects. 15 Furthermore, the collection of dietary data using a standardized 24-HDR in the EPIC cohort allowed the comparison across countries.
In conclusion, these results suggest that there were large differences in dietary TR estimations across European countries. TR could account approximately for half of the total flavonoids in countries where tea is highly consumed, particularly black tea. Further research on TR content values in the various tea brews is needed to get more accurate data on TR intake. A better estimation of TR intakes may enable a better determination of their role in the prevention of certain chronic pathologies, such as cancer and cardiovascular diseases. 
